AKT1 and breast cancer: In BC, EpCAM was found to be hyperglycosylated, whereas deglycosylated EpCAM promoted autophagy and apoptosis, and inhibits proliferation in BC cells through suppressing PI3K/AKT/mTOR pathway [122,123].